Lupin Obtains USFDA Approval for Ranluspec Biosimilar Based on Lucentis
Pharmaceutical company Lupin Ltd announced on Thursday (June 4) that it has obtained approval from the United States Food and Drug…
Cipla Addresses USFDA Form 483 Comments Regarding Supply Partner Pharmathen
On Wednesday (January 7), drug manufacturer Cipla Ltd issued a clarification in response to media reports concerning inspectional observations…